Jennifer Westendorf - Publications

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Biochemistry

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Dudakovic A, Gluscevic M, Paradise CR, Dudakovic H, Khani F, Thaler R, Ahmed FS, Li X, Dietz AB, Stein GS, Montecino MA, Deyle DR, Westendorf JJ, van Wijnen AJ. Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing. Gene. PMID 28132772 DOI: 10.1016/j.gene.2017.01.019  0.72
2016 Lewallen EA, Bonin CA, Li X, Smith J, Karperien M, Larson AN, Lewallen DG, Cool SM, Westendorf JJ, Krych AJ, Leontovich AA, Im HJ, van Wijnen AJ. The synovial microenvironment of osteoarthritic joints alters RNA-seq expression profiles of human primary articular chondrocytes. Gene. PMID 27378743 DOI: 10.1016/j.gene.2016.06.063  0.72
2016 Fang D, Gan H, Lee JH, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, ... ... Westendorf JJ, et al. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science (New York, N.Y.). PMID 27229140 DOI: 10.1126/Science.Aae0065  1
2016 Weivoda MM, Ruan M, Pederson L, Hachfeld C, Davey RA, Zajac JD, Westendorf JJ, Khosla S, Oursler MJ. Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 31: 76-85. PMID 26108893 DOI: 10.1002/jbmr.2586  1
2016 Bradley EW, Carpio LR, McGee-Lawrence ME, Castillejo Becerra C, Amanatullah DF, Ta LE, Otero M, Goldring MB, Kakar S, Westendorf JJ. Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis Osteoarthritis and Cartilage. 24: 1021-1028. DOI: 10.1016/j.joca.2015.12.014  1
2015 Kremer KN, Dudakovic A, Hess AD, Smith BD, Karp JE, Kaufmann SH, Westendorf JJ, van Wijnen AJ, Hedin KE. Histone deacetylase inhibitors target the leukemic microenvironment by enhancing a Nherf1-Protein Phosphatase 1α-TAZ signaling pathway in osteoblasts. The Journal of Biological Chemistry. PMID 26491017 DOI: 10.1074/jbc.M115.668160  1
2015 Bonin CA, Lewallen EA, Baheti S, Bradley EW, Stuart MJ, Berry DJ, van Wijnen AJ, Westendorf JJ. Identification of differentially methylated regions in new genes associated with knee osteoarthritis. Gene. PMID 26484395 DOI: 10.1016/j.gene.2015.10.037  1
2015 Dudakovic A, Camilleri ET, Xu F, Riester SM, McGee-Lawrence ME, Bradley EW, Paradise CR, Lewallen EA, Thaler R, Deyle DR, Larson AN, Lewallen DG, Dietz AB, Stein GS, Montecino MA, ... Westendorf JJ, et al. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2. The Journal of Biological Chemistry. PMID 26424790 DOI: 10.1074/Jbc.M115.672345  1
2015 Bradley EW, Carpio LR, van Wijnen AJ, McGee-Lawrence ME, Westendorf JJ. Histone Deacetylases in Bone Development and Skeletal Disorders. Physiological Reviews. 95: 1359-81. PMID 26378079 DOI: 10.1152/Physrev.00004.2015  1
2015 Oursler MJ, Westendorf JJ, Weivoda MM, Ruan M, Hachfeld CM, Howe A, Davey R, Zajac J, Williams BO, Khosla S. Response to Wnt Signaling Pathways. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 2135-6. PMID 26309234 DOI: 10.1002/jbmr.2694  1
2015 McGee-Lawrence ME, Carpio LR, Schulze RJ, Pierce JL, McNiven MA, Farr JN, Khosla S, Oursler MJ, Westendorf JJ. Hdac3-Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteo-Chondroprogenitor Cells. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26211746 DOI: 10.1002/Jbmr.2602  1
2015 Weivoda MM, Ruan M, Hachfeld CM, Pederson L, Howe A, Davey RA, Zajac JD, Kobayashi Y, Williams BO, Westendorf JJ, Khosla S, Oursler MJ. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26189772 DOI: 10.1002/jbmr.2599  1
2015 Bradley EW, Carpio LR, Newton AC, Westendorf JJ. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation. The Journal of Biological Chemistry. 290: 16272-80. PMID 25953896 DOI: 10.1074/jbc.M114.612937  1
2015 Gordon JA, Stein JL, Westendorf JJ, van Wijnen AJ. Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease. Bone. PMID 25836763 DOI: 10.1016/j.bone.2015.03.011  1
2015 Zou L, Kidwai FK, Kopher RA, Motl J, Kellum CA, Westendorf JJ, Kaufman DS. Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. Stem Cell Reports. 4: 190-8. PMID 25680477 DOI: 10.1016/j.stemcr.2015.01.008  1
2015 McGee-Lawrence ME, White TA, LeBrasseur NK, Westendorf JJ. Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction. Molecular and Cellular Endocrinology. 410: 42-51. PMID 25666992 DOI: 10.1016/J.Mce.2015.02.001  1
2015 Bradley EW, Carpio LR, Olson EN, Westendorf JJ. Histone deacetylase 7 (Hdac7) suppresses chondrocyte proliferation and β-catenin activity during endochondral ossification. The Journal of Biological Chemistry. 290: 118-26. PMID 25389289 DOI: 10.1074/Jbc.M114.596247  1
2015 Lewallen EA, Riester SM, Bonin CA, Kremers HM, Dudakovic A, Kakar S, Cohen RC, Westendorf JJ, Lewallen DG, van Wijnen AJ. Biological strategies for improved osseointegration and osteoinduction of porous metal orthopedic implants. Tissue Engineering. Part B, Reviews. 21: 218-30. PMID 25348836 DOI: 10.1089/ten.TEB.2014.0333  1
2015 Dudakovic A, Camilleri ET, Lewallen EA, McGee-Lawrence ME, Riester SM, Kakar S, Montecino M, Stein GS, Ryoo HM, Dietz AB, Westendorf JJ, van Wijnen AJ. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells. Journal of Cellular Physiology. 230: 52-62. PMID 24912092 DOI: 10.1002/Jcp.24680  1
2014 McGee-Lawrence ME, Carpio LR, Bradley EW, Dudakovic A, Lian JB, van Wijnen AJ, Kakar S, Hsu W, Westendorf JJ. Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice. Bone. 66: 277-86. PMID 24973690 DOI: 10.1016/J.Bone.2014.06.022  1
2014 Dudakovic A, Camilleri E, Riester SM, Lewallen EA, Kvasha S, Chen X, Radel DJ, Anderson JM, Nair AA, Evans JM, Krych AJ, Smith J, Deyle DR, Stein JL, Stein GS, ... ... Westendorf JJ, et al. High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells. Journal of Cellular Biochemistry. 115: 1816-28. PMID 24905804 DOI: 10.1002/jcb.24852  1
2014 Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, Lewis JT, Chou MM, Yaszemski MJ, Jen J, Westendorf JJ, Oliveira AM. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nature Genetics. 46: 666-8. PMID 24859338 DOI: 10.1038/Ng.2989  1
2014 Kremer KN, Dudakovic A, McGee-Lawrence ME, Philips RL, Hess AD, Smith BD, van Wijnen AJ, Karp JE, Kaufmann SH, Westendorf JJ, Hedin KE. Osteoblasts protect AML cells from SDF-1-induced apoptosis. Journal of Cellular Biochemistry. 115: 1128-37. PMID 24851270 DOI: 10.1002/Jcb.24755  1
2014 Bledsoe KL, McGee-Lawrence ME, Camilleri ET, Wang X, Riester SM, van Wijnen AJ, Oliveira AM, Westendorf JJ. RUNX3 facilitates growth of Ewing sarcoma cells. Journal of Cellular Physiology. 229: 2049-56. PMID 24812032 DOI: 10.1002/Jcp.24663  1
2014 Ryan ZC, Craig TA, Salisbury JL, Carpio LR, McGee-Lawrence M, Westendorf JJ, Kumar R. Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone Biochemical and Biophysical Research Communications. 448: 83-88. PMID 24780398 DOI: 10.1016/J.Bbrc.2014.04.092  1
2014 Hinton DJ, McGee-Lawrence ME, Lee MR, Kwong HK, Westendorf JJ, Choi DS. Aberrant bone density in aging mice lacking the adenosine transporter ENT1. Plos One. 9: e88818. PMID 24586402 DOI: 10.1371/Journal.Pone.0088818  1
2013 McGee-Lawrence ME, Ryan ZC, Carpio LR, Kakar S, Westendorf JJ, Kumar R. Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous ossification. Biochemical and Biophysical Research Communications. 441: 886-90. PMID 24211207 DOI: 10.1016/J.Bbrc.2013.10.155  1
2013 McGee-Lawrence ME, Westendorf JJ. Reply to vorinostat induced bone loss in mice. Bone. 57: 531-2. PMID 23973558 DOI: 10.1016/J.Bone.2013.08.019  1
2013 Dudakovic A, Evans JM, Li Y, Middha S, McGee-Lawrence ME, van Wijnen AJ, Westendorf JJ. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation. The Journal of Biological Chemistry. 288: 28783-91. PMID 23940046 DOI: 10.1074/Jbc.M113.489732  1
2013 Ota K, Quint P, Weivoda MM, Ruan M, Pederson L, Westendorf JJ, Khosla S, Oursler MJ. Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. Bone. 57: 68-75. PMID 23891907 DOI: 10.1016/j.bone.2013.07.023  1
2013 van Wijnen AJ, van de Peppel J, van Leeuwen JP, Lian JB, Stein GS, Westendorf JJ, Oursler MJ, Im HJ, Taipaleenmäki H, Hesse E, Riester S, Kakar S. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Current Osteoporosis Reports. 11: 72-82. PMID 23605904 DOI: 10.1007/s11914-013-0143-6  1
2013 McGee-Lawrence ME, Li X, Bledsoe KL, Wu H, Hawse JR, Subramaniam M, Razidlo DF, Stensgard BA, Stein GS, van Wijnen AJ, Lian JB, Hsu W, Westendorf JJ. Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice. The Journal of Biological Chemistry. 288: 5291-302. PMID 23300083 DOI: 10.1074/Jbc.M112.414995  1
2013 McGee-Lawrence ME, Bradley EW, Dudakovic A, Carlson SW, Ryan ZC, Kumar R, Dadsetan M, Yaszemski MJ, Chen Q, An KN, Westendorf JJ. Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone. 52: 296-307. PMID 23085085 DOI: 10.1016/J.Bone.2012.10.015  1
2013 McGee-Lawrence ME, Bradley EW, Dudakovic A, Carlson SW, Ryan ZC, Kumar R, Dadsetan M, Yaszemski MJ, Chen Q, An KN, Westendorf JJ. Corrigendum to "Histone deacetylase 3 is required for maintenance of bone mass during aging" [Bone 52 (2013) 296-307] Bone. 53: 320. DOI: 10.1016/J.Bone.2012.12.005  1
2012 Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ. Update on Wnt signaling in bone cell biology and bone disease. Gene. 492: 1-18. PMID 22079544 DOI: 10.1016/J.Gene.2011.10.044  1
2011 Bradley EW, McGee-Lawrence ME, Westendorf JJ. Hdac-mediated control of endochondral and intramembranous ossification. Critical Reviews in Eukaryotic Gene Expression. 21: 101-13. PMID 22077150 DOI: 10.1615/Critreveukargeneexpr.V21.I2.10  1
2011 Undale A, Fraser D, Hefferan T, Kopher RA, Herrick J, Evans GL, Li X, Kakar S, Hayes M, Atkinson E, Yaszemski MJ, Kaufman DS, Westendorf JJ, Khosla S. Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 29: 1804-11. PMID 21674605 DOI: 10.1002/jor.21480  1
2011 Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, Westendorf JJ, Cheng L, Huang H. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Research. 71: 3257-67. PMID 21505104 DOI: 10.1158/0008-5472.CAN-10-2603  0.6
2011 Hoeppner LH, Secreto FJ, Razidlo DF, Whitney TJ, Westendorf JJ. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. The Journal of Biological Chemistry. 286: 10950-9. PMID 21270130 DOI: 10.1074/jbc.M110.165100  1
2011 McGee-Lawrence ME, McCleary-Wheeler AL, Secreto FJ, Razidlo DF, Zhang M, Stensgard BA, Li X, Stein GS, Lian JB, Westendorf JJ. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. Bone. 48: 1117-26. PMID 21255693 DOI: 10.1016/J.Bone.2011.01.007  1
2011 McGee-Lawrence ME, Westendorf JJ. Histone deacetylases in skeletal development and bone mass maintenance. Gene. 474: 1-11. PMID 21185361 DOI: 10.1016/J.Gene.2010.12.003  1
2010 Pratap J, Akech J, Wixted JJ, Szabo G, Hussain S, McGee-Lawrence ME, Li X, Bedard K, Dhillon RJ, van Wijnen AJ, Stein JL, Stein GS, Westendorf JJ, Lian JB. The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Molecular Cancer Therapeutics. 9: 3210-20. PMID 21159607 DOI: 10.1158/1535-7163.Mct-10-0572  1
2010 Li X, McGee-Lawrence ME, Decker M, Westendorf JJ. The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation. Journal of Cellular Biochemistry. 111: 933-43. PMID 20665663 DOI: 10.1002/Jcb.22782  1
2010 Razidlo DF, Whitney TJ, Casper ME, McGee-Lawrence ME, Stensgard BA, Li X, Secreto FJ, Knutson SK, Hiebert SW, Westendorf JJ. Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. Plos One. 5: e11492. PMID 20628553 DOI: 10.1371/Journal.Pone.0011492  1
2010 Li X, Decker M, Westendorf JJ. TEThered to Runx: novel binding partners for runx factors. Blood Cells, Molecules & Diseases. 45: 82-5. PMID 20362478 DOI: 10.1016/j.bcmd.2010.03.002  0.72
2010 Shimizu E, Selvamurugan N, Westendorf JJ, Olson EN, Partridge NC. HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression Journal of Biological Chemistry. 285: 9616-9626. PMID 20097749 DOI: 10.1074/Jbc.M109.094862  1
2010 Jensen ED, Gopalakrishnan R, Westendorf JJ. Regulation of gene expression in osteoblasts. Biofactors (Oxford, England). 36: 25-32. PMID 20087883 DOI: 10.1002/biof.72  0.6
2010 Jensen ED, Pham L, Billington CJ, Espe K, Carlson AE, Westendorf JJ, Petryk A, Gopalakrishnan R, Mansky K. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. Journal of Cellular Biochemistry. 109: 672-82. PMID 20039313 DOI: 10.1002/jcb.22462  1
2009 Hoeppner LH, Secreto F, Jensen ED, Li X, Kahler RA, Westendorf JJ. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. Journal of Cellular Physiology. 221: 480-9. PMID 19650108 DOI: 10.1002/jcp.21879  1
2009 Secreto FJ, Hoeppner LH, Westendorf JJ. Wnt signaling during fracture repair. Current Osteoporosis Reports. 7: 64-9. PMID 19631031  0.52
2009 Li X, Hoeppner LH, Jensen ED, Gopalakrishnan R, Westendorf JJ. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors. Journal of Cellular Biochemistry. 108: 378-87. PMID 19585539 DOI: 10.1002/jcb.22263  0.72
2009 Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. Expert Opinion On Therapeutic Targets. 13: 485-96. PMID 19335070 DOI: 10.1517/14728220902841961  0.52
2009 Jensen ED, Gopalakrishnan R, Westendorf JJ. Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. The Journal of Biological Chemistry. 284: 2225-34. PMID 19029091 DOI: 10.1074/jbc.M800586200  0.6
2009 Krawczak DA, Westendorf JJ, Carlson CS, Lewis JL. Influence of bone morphogenetic protein-2 on the extracellular matrix, material properties, and gene expression of long-term articular chondrocyte cultures: loss of chondrocyte stability. Tissue Engineering. Part A. 15: 1247-55. PMID 18950256 DOI: 10.1089/Ten.Tea.2008.0249  1
2008 Kahler RA, Yingst SM, Hoeppner LH, Jensen ED, Krawczak D, Oxford JT, Westendorf JJ. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biology : Journal of the International Society For Matrix Biology. 27: 330-8. PMID 18280717 DOI: 10.1016/J.Matbio.2008.01.002  1
2008 Jensen ED, Schroeder TM, Bailey J, Gopalakrishnan R, Westendorf JJ. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 361-72. PMID 17997710 DOI: 10.1359/jbmr.071104  1
2008 Jensen ED, Niu L, Caretti G, Nicol SM, Teplyuk N, Stein GS, Sartorelli V, van Wijnen AJ, Fuller-Pace FV, Westendorf JJ. p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. Journal of Cellular Biochemistry. 103: 1438-51. PMID 17960593 DOI: 10.1002/jcb.21526  1
2007 Schroeder TM, Nair AK, Staggs R, Lamblin AF, Westendorf JJ. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. Bmc Genomics. 8: 362. PMID 17925016 DOI: 10.1186/1471-2164-8-362  1
2007 Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ, van Wijnen AJ. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. Journal of Molecular Histology. 38: 501-6. PMID 17885813 DOI: 10.1007/s10735-007-9143-0  1
2007 Jensen ED, Nair AK, Westendorf JJ. Histone deacetylase co-repressor complex control of Runx2 and bone formation. Critical Reviews in Eukaryotic Gene Expression. 17: 187-96. PMID 17725488  1
2007 Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (Dayton, Ohio). 25: 371-9. PMID 17038675 DOI: 10.1634/Stemcells.2005-0620  1
2006 Kahler RA, Galindo M, Lian J, Stein GS, van Wijnen AJ, Westendorf JJ. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. Journal of Cellular Biochemistry. 97: 969-83. PMID 16267835 DOI: 10.1002/jcb.20702  1
2005 Schroeder TM, Westendorf JJ. Histone deacetylase inhibitors promote osteoblast maturation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 2254-63. PMID 16294278 DOI: 10.1359/JBMR.050813  1
2005 Dong X, Lutz W, Schroeder TM, Bachman LA, Westendorf JJ, Kumar R, Griffin MD. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proceedings of the National Academy of Sciences of the United States of America. 102: 16007-12. PMID 16239345 DOI: 10.1073/pnas.0506516102  1
2005 Schroeder TM, Jensen ED, Westendorf JJ. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Research. Part C, Embryo Today : Reviews. 75: 213-25. PMID 16187316 DOI: 10.1002/bdrc.20043  1
2004 Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 341: 19-39. PMID 15474285 DOI: 10.1016/j.gene.2004.06.044  1
2004 Schroeder TM, Kahler RA, Li X, Westendorf JJ. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. The Journal of Biological Chemistry. 279: 41998-2007. PMID 15292260 DOI: 10.1074/jbc.M403702200  1
2003 Koka S, Neudauer CL, Li X, Lewis RE, McCarthy JB, Westendorf JJ. The formin-homology-domain-containing protein FHOD1 enhances cell migration. Journal of Cell Science. 116: 1745-55. PMID 12665555 DOI: 10.1242/Jcs.00386  0.72
2003 Kahler RA, Westendorf JJ. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. The Journal of Biological Chemistry. 278: 11937-44. PMID 12551949 DOI: 10.1074/jbc.M211443200  1
2002 Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Molecular and Cellular Biology. 22: 7982-92. PMID 12391164  0.72
2000 Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein Molecular and Cellular Biology. 20: 2075-2086. PMID 10688654 DOI: 10.1128/MCB.20.6.2075-2086.2000  1
2000 Strom DK, John N, Westendorf JJ, Linggi B, Lutterbach B, Downing JR, Lenny N, Hiebert SW. Expression of the AML-1 oncogene shortens the G1 phase of the cell cycle Journal of Biological Chemistry. 275: 3438-3445. PMID 10652337 DOI: 10.1074/jbc.275.5.3438  1
2000 Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia Journal of Biological Chemistry. 275: 651-656. PMID 10617663 DOI: 10.1074/jbc.275.1.651  1
1999 Westendorf JJ, Hiebert SW. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia Journal of Cellular Biochemistry. 76: 51-58. PMID 10629103  1
1999 Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR, Hiebert SW. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein Molecular and Cellular Biology. 19: 6566-6574. PMID 10490596  1
1999 Westendorf JJ, Mernaugh R, Hiebert SW. Identification and characterization of a protein containing formin homology (FH1/FH2) domains Gene. 232: 173-182. PMID 10352228 DOI: 10.1016/S0378-1119(99)00127-4  1
1998 Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Molecular and Cellular Biology. 18: 7176-84. PMID 9819404 DOI: 10.1128/Mcb.18.12.7176  1
1998 Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation Molecular and Cellular Biology. 18: 322-333. PMID 9418879  1
1997 Lenny N, Westendorf JJ, Hiebert SW. Transcriptional regulation during myelopoiesis Molecular Biology Reports. 24: 157-168. PMID 9291089 DOI: 10.1023/A:1006859700409  1
1997 Jelinek DF, Aagaard-Tillery KM, Arendt BK, Arora T, Tschumper RC, Westendorf JJ. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression. The Journal of Clinical Investigation. 99: 447-56. PMID 9022078 DOI: 10.1172/JCI119179  1
Show low-probability matches.